The Nutraceutical Genistein-Lycopene Combination Improves Bone Damage Induced by Glucocorticoids by Stimulating the Osteoblast Formation Process

The Nutraceutical Genistein-Lycopene Combination Improves Bone Damage Induced by Glucocorticoids by Stimulating the Osteoblast Formation Process

Chronic glucocorticoid (GC) therapy is the most common cause of iatrogenic osteoporosis and represents an important risk factor for osteoporosis and bone fractures. New therapeutic approaches are required in order to treat osteoporosis and reduce the side effects related to the use of anti-osteoporo...

Full description

Bibliographic Details
Main Authors: Federica Mannino, Tommaso D’Angelo, Giovanni Pallio, Antonio Ieni, Igor Pirrotta, Domenico Antonio Giorgi, Alessandro Scarfone, Silvio Mazziotti, Christian Booz, Alessandra Bitto, Francesco Squadrito, Natasha Irrera
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Nutrients
Subjects:
osteoporosis
GIO
genistein
lycopene
nutraceuticals
Online Access:https://www.mdpi.com/2072-6643/14/20/4296

Internet

https://www.mdpi.com/2072-6643/14/20/4296

Similar Items